Enjaymo 50 mg / mL solution for infusion

Licence status
Authorised: 15/11/2022
Active substances
Sutimlimab
Dosage Form
Solution for infusion
Licence number
EU/1/22/1687/001-002
Licence holder
Recordati Rare Diseases

Product documents

Licence information

ATC code
L04 IMMUNOSUPPRESSANTS, L04AA55 Sutimlimab
Legal supply status
Product subject to prescription which may not be renewed (A)
Place of sale
Supply through pharmacies only
Conditions of Licence
Medicinal product subject to restricted medical prescription (see Annex I: Summary of Product Characteristics, section 4.2).
Marketing availability
Unknown
Advertising conditions
Advertising to healthcare professionals only
Licence issued
15/11/2022